Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Gadolinium Compounds Provide Insights into Pathogenesis of Fibrosing Diseases

Lara C. Pullen, PhD  |  November 9, 2012

Omniscan induced NF-ĸB–dependent secreted alkaline phosphatase (SEAP) production (reporter gene) in HEK293 cells expressing either TLR4 or TLR7. The authors found that only some of the Gd compounds (Omniscan and gadodiamide) induced significantly increased SEAP production in a dose-dependent manner. The other Gd compounds (MultiHance, Dotarem, Gd-EDTA, and Gd-citrate, GdBCA, Gd-DTPA, OptiMark, or ProHance) did not induce robust reporter gene activation.

The authors then examined the effects of Omniscan and gadodiamide on normal human macrophages cultured in the presence of macrophage colony-stimulating factor (M-CSF) and interleukin (IL) 10. Analysis by real-time polymerase chain reaction revealed that Omniscan and gadodiamide both caused markedly upregulated expression of multiple chemokines, cytokines, and growth factors. These include CXCL10, CCL2, CCL8, CXCL12, IL-4, IL-6, TGF-β, and vascular endothelial growth factor. Searchlight proteome multiplex arrays confirmed that the increase in gene expression translated into increased protein production. CXCL10 stood out because it had a maximal 20-fold induction (gene expression) by gadodiamide when compared with the saline control. These effects were blocked by the TLR inhibitors chloroquine and IL-1R–asociated kinase (IRAK) 1 and 4.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Pullen is a medical writer based in the Chicago area.

Reference

1. Wermuth PJ, Jimenez SA. Gadolinium compounds signaling through TLR4 and TLR7 in normal human macrophages: Establishment of a proinflammatory phenotype and implications for the pathogenesis of nephrogenic systemic fibrosis. J Immunol. 2012;189:318-27.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

 

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsResearch RheumSystemic Sclerosis Tagged with:Nephrogenic Systemic FibrosisSystemic sclerosisToll-like receptors

Related Articles

    Doest Rheumatoid Arthritis Take a Toll?

    November 15, 2013

    Exploring the Toll background

    What Causes Nephrogenic Systemic Fibrosis?

    September 1, 2007

    Imaging studies and kidney problems may trigger this gadolinium-induced fibrosing syndrome

    Professor Shares Findings from 45 Years of Lupus Research

    March 18, 2018

    SAN DIEGO—What are the predisposing genes that suggest who will develop active systemic lupus erythematosus and who will stay healthy? Decades of research data help rheumatologists clarify this picture, says Argyrios N. Theofilopoulos, MD, professor of immunology and microbiology at Scripps Research Institute in La Jolla, Calif. At his Nov. 5 lecture at the 2017…

    FOCIS 2015: Key Protein Found to Control Trafficking of Toll-like Receptors

    October 13, 2015

    Gregory Barton, PhD, professor of immunology and pathogenesis, University of California, Berkeley, talked about research on the innate immune system and a key protein involved in the trafficking of a subset of toll-like receptors (TLRs) during FOCIS 2015 in San Diego. To keep the body healthy, the immune system responds constantly to foreign cellular invaders…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences